Stalevo Film Coated Tablet 200/50/200mg
Product details
Registration number: SIN13566P
Classification: Prescription Only
Active ingredients:
- Carbidopa monohydrate 54.1mg corresponds to carbidopa
- Entacapone
- Levodopa
Strength:
- 50mg
- 200mg
- 200mg
Dosage form: TABLET, FILM COATED
Route: ORAL
Registrant: ORION PHARMA (SG) PTE. LTD.
ATC code: N04BA03
HSA approval date: 3 November 2008
Manufacturer(s): Orion Corporation, Orion Pharma (Espoo site)
Manufacturing country/countries: FINLAND
What are the HSA registration number and classification for Stalevo Film Coated Tablet 200/50/200mg?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN13566P
Classification: Prescription Only
What active ingredients and strength are recorded for Stalevo Film Coated Tablet 200/50/200mg?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- Carbidopa monohydrate 54.1mg corresponds to carbidopa
- Entacapone
- Levodopa
Strength:
- 50mg
- 200mg
- 200mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for Stalevo Film Coated Tablet 200/50/200mg?
According to the HSA dataset updated 7 August 2026:
Dosage form: TABLET, FILM COATED
Route: ORAL
Who is the recorded registrant for Stalevo Film Coated Tablet 200/50/200mg?
According to the HSA dataset updated 7 August 2026:
Registrant: ORION PHARMA (SG) PTE. LTD.
Which manufacturers and countries are listed for Stalevo Film Coated Tablet 200/50/200mg?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Orion Corporation, Orion Pharma (Espoo site)
Manufacturing country/countries: FINLAND
Where can I look up Stalevo Film Coated Tablet 200/50/200mg in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN13566P or the exact product name Stalevo Film Coated Tablet 200/50/200mg. The general register link does not preselect this product.
What are the source dates for this Stalevo Film Coated Tablet 200/50/200mg record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this Stalevo Film Coated Tablet 200/50/200mg record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN13566P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)